Restanza's New Hope: Advance Life Sciences To Conduct New Pivotal Trials

Company sees options in recommendations from FDA advisory committees for community-acquired bacterial pneumonia and for use of animal efficacy rule for biodefense indications.

More from Archive

More from Pink Sheet